Twitter | Search | |
Aju Mathew
Cancer doc, public health and global oncology researcher. via Trivandrum, Stockholm, Cambridge and Pittsburgh.
2,098
Tweets
263
Following
400
Followers
Tweets
Aju Mathew 3h
Reply Retweet Like
Aju Mathew 5h
- Arnab Goswami is an abomination for journalism.
Reply Retweet Like
Aju Mathew 15h
NGS not done. Patient died within a month of this prescripn.
Reply Retweet Like
Aju Mathew 16h
Replying to @oncology_bg
?
Reply Retweet Like
Aju Mathew 16h
Edited version of a prescr I saw today. Erlotinib for metastatic pancreatic ca. For a 10 day median survival benefit.
Reply Retweet Like
Aju Mathew 17h
No. I wouldn't be able to maintain my sanity.
Reply Retweet Like
Aju Mathew 17h
Replying to @Aiims1742
Sadly, all too common. It's tremendously confusing to patients.
Reply Retweet Like
Aju Mathew 23h
Replying to @VinayPrasad82
Great open ed. I think there must be a good balance. Some of these awards do inspire scientists. But, yes, replication is under emphasizd.
Reply Retweet Like
Aju Mathew Sep 19
It's terrifying when India's PM follows rumor mongers who are trying to create hatred. At bare minimum, he shd unfollow.
Reply Retweet Like
Aju Mathew Sep 19
Simply crazy. Why would there be spectators there?
Reply Retweet Like
Aju Mathew Sep 19
Predatory journals harm science. The rot begins at the top. Don't just blame the guys who run the predatory websites.
Reply Retweet Like
Aju Mathew Sep 19
Sadly, he works at one of the nation's premier institutions and is well funded by federal grants.
Reply Retweet Like
Aju Mathew Sep 19
He replied and said he is aware of it. And he stated that it is an "excellent journal".
Reply Retweet Like
Aju Mathew Sep 19
I browsed through the editorial board and saw a familiar face and name. I emailed him to check if he knows he is listed as an editor.
Reply Retweet Like
Aju Mathew Sep 19
Few days ago, I got a similar mail that I was sure was a predatory journal. In fact, I found the owner of the website.
Reply Retweet Like
Aju Mathew Sep 19
😀 It's my lucky day. The same journal emailed me too.
Reply Retweet Like
Aju Mathew Sep 18
Replying to @GenaBigler
Thank you Gena.
Reply Retweet Like
Aju Mathew Sep 18
All of these are clinically meaningful events we want to avoid by using drug X.
Reply Retweet Like
Aju Mathew Sep 18
Essentially, it avoid measuring non-invasive conditions, like DCIS (stage 0).
Reply Retweet Like
Aju Mathew Sep 17
Now Vinay is aiming at the breast oncologists. God, save us! :) As they say in the UK, nice one mate.
Reply Retweet Like